Finance

Lists
197A:TYO
TAUNS Laboratories Inc
JP¥509,00
-0,97%
(-5,00) 1D
2 Okt., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 197A...
Open
JP¥514
High
JP¥514
Low
JP¥507
Mkt. cap
54,35 mjd
Avg. vol.
217,19 k
Volume
120,60 k
Dividend
5,50%
Quarterly dividend
JP¥7
Ex-dividend date
29 Des. 2025
P/E ratio
26,06
52-wk high
JP¥577
52-wk low
JP¥463
EPS
JP¥20
No. of employees
316
Open
JP¥514
High
JP¥514
Low
JP¥507
Mkt. cap
54,35 mjd
Avg. vol.
217,19 k
Volume
120,60 k
Dividend
5,50%
Quarterly dividend
JP¥7
Ex-dividend date
29 Des. 2025
P/E ratio
26,06
52-wk high
JP¥577
52-wk low
JP¥463
EPS
JP¥20
No. of employees
316
News stories
From web sources and news partners
About TAUNS Laboratories Inc
CEO-
Employees316
Founded14 Apr. 2016
Headquarters-
SectorMedical device
Websitetauns.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
2,37 mjd
5,91 mjd
2,39 mjd
3,71 mjd
Cost of goods sold
738,40 m
1,91 mjd
975,84 m
1,93 mjd
Cost of revenue
738,40 m
1,91 mjd
975,84 m
1,93 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,08 mjd
1,30 mjd
1,15 mjd
562,14 m
Operating expense
1,08 mjd
1,30 mjd
1,15 mjd
1,09 mjd
Total operating expenses
1,82 mjd
3,20 mjd
2,13 mjd
3,02 mjd
Operating income
547,52 m
2,70 mjd
257,70 m
690,43 m
Other non operating income
-20,00 k
-2,98 m
413,16 m
3,95 mjd
EBT including unusual items
506,19 m
2,40 mjd
601,46 m
4,39 mjd
EBT excluding unusual items
505,33 m
2,64 mjd
611,80 m
4,56 mjd
Income tax expense
148,28 m
697,27 m
218,44 m
1,34 mjd
Effective tax rate
29,29%
29,05%
36,32%
30,46%
Other operating expenses
-
-
-
-
Net income
357,90 m
1,70 mjd
383,02 m
3,05 mjd
Net profit margin
15,11%
28,82%
16,05%
82,35%
Earnings per share
-
-
-
-
Interest and investment income
8,58 m
767,00 k
13,49 m
981,00 k
Interest expense
-50,75 m
-61,20 m
-72,56 m
-79,53 m
Net interest expenses
-42,17 m
-60,43 m
-59,07 m
-78,55 m
Depreciation and amortization charges
-
-
-
527,20 m
EBITDA
726,38 m
2,90 mjd
436,56 m
971,69 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme